The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The GPIHBP1–LPL Complex Is Responsible for the Margination of Triglyceride-Rich Lipoproteins in Capillaries
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
GPIHBP1 anchors LPL to the capillary wall during lipolysis of lipoproteins.
“GPIHBP1 also anchors LPL to the capillary wall during lipolysis of lipoproteins (8, 9).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
Flagged first, then by citations
Research works printed but not linked: 35
- Arkill, 2012, 3D reconstruction of the glycocalyx structure in mammalian capillaries using electron tomography, Microcirculation, 19, 343, 10.1111/j.1549-8719.2012.00168.x · DOI
- Beigneux, 2007, Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons, Cell Metab., 5, 279, 10.1016/j.cmet.2007.02.002 · DOI · Paper page
- Blanchette-Mackie, 1989, Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study, Am. J. Physiol., 256, E818
- Cardin, 1984, Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100, Thromb. Res., 34, 541, 10.1016/0049-3848(84)90258-5 · DOI
- Cardin, 1986, Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains, Biochem. Biophys. Res. Commun., 134, 783, 10.1016/S0006-291X(86)80489-2 · DOI
- Chang, 1998, Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2, J. Lipid Res., 39, 2350, 10.1016/S0022-2275(20)33314-9 · DOI
- Cryer, 1989, The role of the endothelium in myocardial lipoprotein dynamics, Mol. Cell. Biochem., 88, 7, 10.1007/BF00223417 · DOI
- Davies, 2010, GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries, Cell Metab., 12, 42, 10.1016/j.cmet.2010.04.016 · DOI · Paper page
- Davies, 2012, Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells, J. Lipid Res., 53, 2690, 10.1194/jlr.M031559 · DOI
- Garcia-Arcos, 2013, Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology, J. Biol. Chem., 288, 14046, 10.1074/jbc.M113.469270 · DOI · Paper page
- Gin, 2011, Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells, Arterioscler. Thromb. Vasc. Biol., 31, 176, 10.1161/ATVBAHA.110.214718 · DOI
- Goldberg, 1996, Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis, J. Lipid Res., 37, 693, 10.1016/S0022-2275(20)37569-6 · DOI
- Grobe, 2002, Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes, Biochim. Biophys. Acta, 1573, 209, 10.1016/S0304-4165(02)00386-0 · DOI
- Kobayashi, 2002, Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain, Eur. J. Biochem., 269, 4701, 10.1046/j.1432-1033.2002.03179.x · DOI
- Levak-Frank, 1997, Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma, J. Biol. Chem., 272, 17182, 10.1074/jbc.272.27.17182 · DOI
- Lichtenstein, 2010, Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages, Cell Metab., 12, 580, 10.1016/j.cmet.2010.11.002 · DOI · Paper page
- Liu, 1992, Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity, Biochim. Biophys. Acta, 1128, 113, 10.1016/0005-2760(92)90264-V · DOI
- Lookene, 1997, Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties, J. Biol. Chem., 272, 766, 10.1074/jbc.272.2.766 · DOI
- Lookene, 2005, Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism, J. Biol. Chem., 280, 25383, 10.1074/jbc.M501589200 · DOI
- Mastronarde, 1997, Dual-axis tomography: an approach with alignment methods that preserve resolution, J. Struct. Biol., 120, 343, 10.1006/jsbi.1997.3919 · DOI
- Merkel, 1998, Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo, Proc. Natl. Acad. Sci. USA, 95, 13841, 10.1073/pnas.95.23.13841 · DOI
- Moore, 1957, The fine structure of capillaries and small arteries, J. Biophys. Biochem. Cytol., 3, 457, 10.1083/jcb.3.3.457 · DOI
- Moore, 2012, Elemental imaging at the nanoscale: NanoSIMS and complementary techniques for element localisation in plants, Anal. Bioanal. Chem., 402, 3263, 10.1007/s00216-011-5484-3 · DOI
- Mullick, 2002, Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall, Arterioscler. Thromb. Vasc. Biol., 22, 2080, 10.1161/01.ATV.0000040221.70377.19 · DOI
- Olafsen, 2010, Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning, J. Biol. Chem., 285, 39239, 10.1074/jbc.M110.171041 · DOI · Paper page
- Olivecrona, 1977, Heparin-lipoprotein lipase interactions, Fed. Proc., 36, 60
- Reitsma, 2007, The endothelial glycocalyx: composition, functions, and visualization, Pflugers Arch., 454, 345, 10.1007/s00424-007-0212-8 · DOI
- Robertson, 1960, The molecular structure and contact relationships of cell membranes, Prog. Biophys. Mol. Biol., 10, 343
- Sonnenburg, 2009, GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4, J. Lipid Res., 50, 2421, 10.1194/jlr.M900145-JLR200 · DOI · Paper page
- Stalenhoef, 1986, Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia, J. Clin. Invest., 78, 722, 10.1172/JCI112632 · DOI · Paper page
- Takahashi, 2008, In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation, Arterioscler. Thromb. Vasc. Biol., 28, 455, 10.1161/ATVBAHA.107.153239 · DOI
- Wang, 2005, Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses, Nat. Immunol., 6, 902, 10.1038/ni1233 · DOI · Paper page
- Weinstein, 2008, Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice, J. Biol. Chem., 283, 34511, 10.1074/jbc.M806067200 · DOI · Paper page
- Weinstein, 2012, Reciprocal metabolic perturbations in the adipose tissue and liver of GPIHBP1-deficient mice, Arterioscler. Thromb. Vasc. Biol., 32, 230, 10.1161/ATVBAHA.111.241406 · DOI
- Wong, 1997, A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase, Proc. Natl. Acad. Sci. USA, 94, 5594, 10.1073/pnas.94.11.5594 · DOI
Cited by
Sorted by citations
GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance
Luan, H. H., Wang, A., Hilliard, B. K., Carvalho, F., Rosen, C. E., Ahasic, A. M., Herzog, E. L., Kang, I., Pisani, M. A., Yu, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.033 · Cited by 527
Wolska, A., Dunbar, R. L., Freeman, L. A., Ueda, M., Amar, M. J., Sviridov, D. O., & Remaley, A. T. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.025 · Cited by 231
Lipoprotein lipase and its regulators: an unfolding story
Wu, S. A., Kersten, S., & Qi, L. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.11.005 · Cited by 225
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Triglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0745-6 · Cited by 90
Borén, J., Watts, G. F., Adiels, M., Söderlund, S., Chan, D. C., Hakkarainen, A., Lundbom, J., Lundbom, N., Matikainen, N., Kahri, J., et al. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305614 · Cited by 72
Dijk, W., Ruppert, P. M. M., Oost, L. J., & Kersten, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002426 · Cited by 72
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
Ramms, B., Patel, S., Nora, C., Pessentheiner, A. R., Chang, M. W., Green, C. R., Golden, G. J., Secrest, P., Krauss, R. M., Metallo, C. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093740 · Cited by 59
Self-citation
Metadata
- Authors
- Goulbourne, C. N., Gin, P., Tatar, A., Nobumori, C., Hoenger, A., Jiang, H., Grovenor, C. R. M., Adeyo, O., Esko, J. D., Goldberg, I. J., Reue, K., Tontonoz, P., Bensadoun, A., Beigneux, A. P., Young, S. G., & Fong, L. G.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 19
- Issue
- 5
- Pages
- 849-860
- ISSN
- 1550-4131
- PMC
- PMC4143151
- Cited by
- 149
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review